Optimal radiotherapy treatment planning using minimum entropy models by Barnard, Richard et al.
OPTIMAL RADIOTHERAPY TREATMENT PLANNING USING
MINIMUM ENTROPY MODELS
RICHARD BARNARD∗ , MARTIN FRANK, MICHAEL HERTY
RWTH AACHEN UNIVERSITY, AACHEN GERMANY
Abstract. We study the problem of finding an optimal radiotherapy treat-
ment plan. A time-dependent Boltzmann particle transport model is used to
model the interaction between radiative particles with tissue. This model al-
lows for the modeling of inhomogeneities in the body and allows for anisotropic
sources modeling distributed radiation—as in brachytherapy—and external
beam sources—as in teletherapy. We study two optimization problems: mini-
mizing the deviation from a spatially-dependent prescribed dose through a qua-
dratic tracking functional; and minimizing the survival of tumor cells through
the use of the linear-quadratic model of radiobiological cell response. For each
problem, we derive the optimality systems. In order to solve the state and ad-
joint equations, we use the minimum entropy approximation; the advantages
of this method are discussed. Numerical results are then presented.
1. Introduction
Radiotherapy is one of the main tools currently in use for the treatment of can-
cer. Radiation is deposited in the tissue with the aim of damaging tumor cells and
disrupting their ability to reproduce. In this paper, we are interested in the treat-
ment planning problem. We wish to determine a method of delivering a sufficient
level of radiative energy to the tumor cells to ensure cell death. This is balanced
by our our desire to minimize damage to healthy tissue, especially specific critit-
cal structures—which we call regions at risk—that should be damaged as little as
possible. This problem can be divided into two phases. First, one must deter-
mine an appropriate external source of radiation that optimally balances these two
competing goals. Secondly, one must devise a means to administer this external
source through (in the case of teletherapy) the selection of beam angles and sim-
ilar parameters. We focus on the first of these steps. Once the optimal source is
determined, the means of creating such a source would still need to be obtained.
Often, the optimal dose will be determined manually and iteratively by an expe-
rienced dosimetrist; this dose consists of selecting several fixed beam angles and
strengths. However, newer methods such as Intensity Modulated Radiation Ther-
apy allow for dynamic sources; such a method requires more automated algorithms
for determining the treatment scheme [13].
Quantifying what the “best” treatment plan is difficult and still unsettled (see
[13],[12] for instance). Often a heuristic approach is used by technicians. Here,
we will study two different means of measuring the effectiveness of a given source.
First, we use a general measure: we look to minimize the deviation from a desired
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distribution of radiation, similar to the objective functional used in [13], [2],[10],
and [9]. The other method we focus on involves using radiobiological parameters
describing cells’ susceptibility to damage from radiation. The cells’ response to
the delivered dose is modeled by the frequently-used linear-quadratic model for cell
death. A significant difficulty in using this model is that the parameters for cell
damage are dependent on several factors leading to significant levels of interpatient
heterogeneity [16],[18],[8],[14]. Furthermore, the parameters can change over the
course of treatment plans as patients exhibit changing levels of radiosensitivity. In
particular, [8] studied the optimal treatment planning problem and the dependence
of the optimal dose on different parameters, especially in the face of changing
radiosensitivity. In [14], a method for treatment planning that accounts for the
uncertainty in an individual’s specific linear-quadratic parameters was developed.
As described in [10], the Fermi-Eyges theory of radiation is used for most dose
calculation algorithms; this theory fails to incorporate properly physical interactions
in areas where inhomogeneities such as void-like regions occur. Here, we will make
use of a Boltzmann transport model which describes the scattering and absorb-
ing effects of the tissue while also allowing for inhomogeneities. Our optimization
method here differs in two significant ways from that in [10]. First, our model is
time-dependent; we will allow for time-dependent, anisotropic sources which are
external (teletherapy) as well as sources distributed in the tissue (brachytherapy).
Second, as opposed to the spherical harmonics approximation used there, we will
make use of a minimum entropy approximation to the Boltzmann transport model
which has the benefit of maintaining several desirable physical properties from the
original model.
In Section 2, we will introduce the Boltzmann transport model describing the
interactions of the radiation with the tissue and the two objective functionals which
we use to measure the effectiveness of a given dose. In Section 3 we establish
optimality conditions for both objective functionals through the adjoint equations
of the Boltzmann equation. From there, we introduce the minimum entropy (M1)
approximation and briefly discuss the advantages of this approximation. Numerical
results in two dimensions are presented for several test cases in Section 5.
2. Mathematical Model
2.1. Transport Equation. Let Z ⊂ R3 be an open, convex, bounded domain with
smooth boundary and outward normal n(x), and T > 0 be given. The direction of a
particle’s movement is Ω ∈ S2 where S2 is the 3-dimensional unit sphere. Then we
model particle transport with sources q, q1 : [0, T ]× R3 × S2 → R by the following
equation
ψt(t, x,Ω) + Ω · ∇xψ(t, x,Ω) + σt(x)ψ(t, x,Ω) = σs(x)
∫
S2
s(x,Ω · Ω′)ψ(t, x,Ω′)dΩ′
(1)
+ q(t, x,Ω)
with boundary condition
(2)
ψ(t, x,Ω) = q1(t, x,Ω), ∀(t, x,Ω) ∈ Γ− := {(t, x,Ω) : t ∈ [0, T ], x ∈ ∂Z, n(x)·Ω < 0}
and initial condition
(3) ψ(0, x,Ω) = 0, ∀(x,Ω) ∈ Z × S2.
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It should be noted that, (1) does not explicitly include the energy dependence of
the transport of particles. However, as detailed in [9], the Boltzmann Continuous
Slowing Down model, which does include energy dependence, can be transformed
into a problem such as (1) where the initial-value condition intuitively describes the
physically reasonable condition that no particles are of “infinite” energy. In general,
the term q denotes a distributed radiative source which would be appropriate for
applications in brachytherapy; meanwhile, q1 seems a natural means of modeling
the effects of external beams in teletherapy applications. However, as described in
Section 4, the role of the control on the incoming boundary is difficult to model in
the context of the M1 approximation (along with similar moment approximations)
to (1). With this in mind, throughout this paper we will assume q1 ≡ 0; that is, we
will replace (2) with the incoming boundary condition
(4) ψ(t, x,Ω) = 0, ∀(t, x,Ω) ∈ Γ−.
We will address in Section4 a means of modeling the case of teletherapy using
the distributed control. The quantity ψ(t, x,Ω) cos θdAdΩ is interpreted as the
number of particles at time t passing through dA at x in the direction dΩ near Ω
where θ is the angle between Ω and dA. The total cross-section σt(x) is the sum
of the absorption cross-section σa(x) and scattering cross-section σs(x). Finally,
the scattering kernel—intuitively describing the probability of a particle changing
direction from Ω′ to Ω at x ∈ Z after a scattering event—is normalized; that is, it
satisfies for all x, ∫ 1
−1
s(x, η)dη =
1
2pi
.
In this paper, we will usethe simplified Henyey-Greenstein kernel (see [1] for more)
sHG(x, η) :=
1− g(x)2
4pi(1 + g(x)2 − 2g(x)η)3/2
where g is the average cosine of the scattering angle. Following [10], we define the
operators
(Aψ)(t, x,Ω) = −ψt(t, x,Ω)− Ω · ∇xψ(t, x,Ω)
(Kψ)(t, x,Ω) = σs(x)
∫
S2
s(x,Ω′ · Ω)ψ(t.x,Ω′)dΩ′
(Σψ)(t, x,Ω) = σt(x)ψ(t, x,Ω)
and make the following general assumptions:
(H-1) σt, σs, s ≥ 0,
(H-2) σt, σs ∈ L∞(Z),
(H-3) σt(x)− σs(x) ≥ α > 0, ∀x ∈ Z.
We note that (H-1) and (H-2) are reasonable physically and that as long as
the medium under consideration is absorbing, the coercivity hypothesis (H-3) is
satisfied. These assumptions imply that the operators
K,Σ : L2([0, T ]× Z × S2)→ L2([0, T ]× Z × S2)
are bounded and linear operators. Finally, we note that if we define
D(A) = {ψ ∈ L2([0, T ]× Z × S2) : ψt,Ω · ∇xψ ∈ L2([0, T ]× Z × S2)},
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then
A : D(A)→ L2([0, T ]× Z × S2)
is a well-defined linear operator. We also let D˜(A) denote the set of functions of
D(A) which also satisfy (4) and (3), for q1 ≡ 0. Then we can conclude—for instance,
by Ch. XXI, 2, Theorem 3 of [5] the following holds.
Theorem 2.1. Suppose that (H-1)-(H-3) hold and that q1 ∈ L2([0, T ]×Z ×S2) is
nonnegative. Then (1) has a unique solution ψ ⊂ ˜D(A).
We define the control-to-state mapping
E : L2([0, T ]× Z × S2)→ D(A)
as the map which maps a source q to the corresponding solution ψ to
−Aψ + Σψ = Kψ + q
subject to (4) and (3). By the above, this is a well-defined, linear operator. As in
[10], it is also bounded.
Proposition 2.1. Let 〈·, ·〉2 denote the standard inner product on L2([0, T ]× Z ×
S2). Then it holds that, for ψ satisfying (4) and (3),
〈−Aψ + Σψ −Kψ,ψ〉2 ≥ α||ψ||22
and thus E is a bounded operator.
Proof. We note that, by an argument analogous to the proof of Lemma 3.1 of [10],
〈Σψ −Kψ,ψ〉2 ≥ α||ψ||22.
Additionally, by integration by parts and the initial and boundary conditions,
〈−Aψ,ψ〉2 =
∫
[0,T ]×Z×S2
(ψtψ)dtdxdΩ +
∫
[0,T ]×Z×S2
(Ω · ∇xψ)ψdtdxdΩ
=
∫
Z×S2
1
2
ψ2(T, x,Ω)dxdΩ +
∫
[0,T ]
∫
Z
div
(∫
S2
1
2
Ωψ2dΩ
)
dxdt
=
∫
Z×S2
1
2
ψ2(T, x,Ω)dxdΩ +
∫
[0,T ]
∫
∂Z×S2
1
2
(Ω · n(x))+ψ2dxdΩdt ≥ 0.
Combining the two inequalities gives the desired result. 
2.2. Objective Functionals. We consider two objective functionals. In each case,
we neglect the incoming boundary source term by fixing q1 ≡ 0 for reasons which
are discussed in 4. Also, we are primarily interested only in the total dose deposited
as a function of x, which we denote by the operator D : L2([0, T ]×Z×S2)→ L2(Z)
which is defined as
Dψ(x) :=
∫
[0,T ]×S2
ψ(t, x,Ω)dtdΩ.
The first functional is a quadratic tracking which measures the deviation from a
prescribed dose D(x)
(5) JT (ψ, q) :=
∫
Z
c1(Dψ −D)2dx+
∫
Z
c2D(q)
2dx.
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Here c1, c2 > 0 are spatially dependent weighting functions. One such weighting
function, used in [10], for c1 is
c1 = cTχZT + cRχZR + cNχZN ,
where cT , cR, cN are constants and ZT , ZR, ZN are, respectively, the portions of Z
corresponding to the tumor, a region at risk, and normal tissue with Z = ZT ∪
ZR ∪ ZN . This functional differs slightly from that studied in [10] in that we are
concerned with the dose deposited but the source is allowed to be angle-dependent.
In that work, the objective functional studied for anisotropic controls also assumed
a desired anisotropic distribution was to be tracked, as opposed to simply a total
dose. Though this objective functional does not attempt to model cell response
to the dose, it does have the benefits of not requiring as inputs the radiobiological
parameters needed for such a model.
The second objective functional involves modeling cell death as a function of
D(ψ). We will use the linear-quadratic model ([14]), neglecting cell growth and
repair rates. In a reference volume for a given dose D, the fraction of surviving
cells of a single type is given by
(6) SF = exp(−αD − βD2)
where α, β are parameters dependent the type of cell being irradiated. This model
has been used extensively for determining dose strategies (for instance, [4, 16, 15, 18,
11] and, in a modified form, [8]). The surviving fraction is often used to determine
the tumor control probability for a given region:
TCP = exp
∫ (
− ρ exp(−αiDi − βiD2i )
)
where ρ is the density of tumor cells as a function of space. We consider a continuous
measure of the number of surviving cells of the various cell types in Z. We consider
a single type of tumor cell and assign this cell type the index 0. The remaining
cell types are given index i = 1, . . . , N. Then, for cell densities ρi(x) ≥ 0 with∑N
i=0 ρi(x) = 1, we define
JSF (ψ, q) := a0
∫
Z
ρ0 exp
[− α0Dψ − β0(Dψ)2](7)
+
N∑
i=1
ai
∫
Z
ρi
(
1− exp [− αiDψ − βi(Dψ)2])
+
c2
2
∫
Z
(Dq)2
where we assign constant weights for each cell type ai > 0 and the control c2 > 0.
For either cost functional, we set U(x) ≥ 0 to be the maximum allowed source
at x ∈ Z. Let L2ad([0, T ] × Z × S2) denote the set of admissible controls–that is,
those controls satisfying q ≥ 0 and∫
S2
q(t, x,Ω)dΩ ≤ U(x)
almost everywhere. Note that this subset of L2([0, T ]×Z×S2) is nonempty, closed,
and convex.
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3. Optimality conditions
We are, then, interested in two separate optimal control problems: the mini-
mization of tracking error
(PT ) min
ψ∈D˜(A),q∈L2ad[0,T ]×Z×S2)
JT (ψ, q), s.t. E(q) = ψ.
and the minimization of tumor cell surviving fraction balanced against normal cell
death
(PSF ) min
ψ∈D˜(A),q∈L2ad([0,T ]×Z×S2)
JSF (ψ, q), s.t. E(q) = ψ.
In order to obtain optimality conditions for PT and PSF , we follow the example of
[17]. One of the advantages of using JT as the objective functional is the following:
Theorem 3.1. Given (H-1)-(H-3), and ψ ∈ D˜(A) with D = D(ψ) and c1, c2 > 0,
then PT has a unique solution q∗ ∈ L2ad([0, T ]× Z × S2).
Proof. We note that the reduced objective functional jT (q) = JT (E(q), q) is a con-
vex functional over the closed,convex set L2ad([0, T ]× Z × S2) of the Hilbert space
L2([0, T ] × Z × S2) and that E is linear and bounded. By Theorem 2.16 of [17],
there exists a unique minimizer for problem PT . 
We now turn to the existence of an optimal control for PSF . Because the asso-
ciated reduced objective functional is nonconvex, we can not assume existence of a
unique optimal control.
Theorem 3.2. Given (H-1)-(H-3) and ci, a > 0 there exists at least one optimal
control q∗ ∈ L2ad([0, T ]× Z × S2) for PSF .
Proof. We note that JSF is convex with respect to q and that the set of admissible
controls is closed, convex, and bounded. This, coupled with the boundedness of the
operator E allows us to conclude that the infimum of JSF over L2ad([0, T ]×Z×S2)
is finite and that any weakly convergent minimizing sequence of controls qn will
converge to an admissible control q∗. By the linearity of A,Σ,K, we conclude that
the corresponding solutions converge strongly to a solution corresponding to the
q∗. (see Theorem 5.7 of [17]). The convexity of JSF as a functional of q allows us
to conclude this control is optimal, as in Theorem 4.15 of [17]. 
We next note the following from [5]:
Proposition 3.1. Under (H-1)-(H-3), for any r ∈ L2([0, T ]× Z × S2),
Aλ+ Σλ−Kλ = r
λ = 0 on Γ+
λ(T, x,Ω) = 0, ∀(x,Ω) ∈ Z × S2.
has a unique solution λ ∈ L2([0, T ]×Z×S2), and the solution operator E∗ is linear,
bounded, and the adjoint to E .
Now, we are ready to turn to the optimality conditions for PT , which is similar
to that found in [10].
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Theorem 3.3. For a desired distribution D ∈ L2(Z) and under the assumptions
(H-1)-(H-3), q∗ ∈ L2ad([0, T ]× Z × S2) is the unique optimal solution to PT if and
only if
(8) q∗(t, x,Ω) = proj
[0,U(x)]
(
− 1
c2(x)
λ∗(t, x,Ω)
)
where λ∗ = E∗(c1(D(ψ∗) −D)), ψ∗ = E(q∗), and projS(·) denotes projection onto
the closed set S.
Proof. The gradient of jT is c1E∗(DE(q∗)−D)) + c2Dq and so we conclude, using
the same arguments of Theorem 2.25, Lemma 2.26, and Theorem 2.27 of [17]. 
This means that the optimality system for PT is
(9)

−Aψ∗ + Σψ∗ = Kψ∗ + q∗,
Aλ∗ + Σλ∗ = Kλ∗ + c1D(E(q∗)−D),
q∗ = proj[0,U(x)](− 1c2λ∗)
with ψ∗ satisfying (4) and (3), λ∗ = 0 on Γ+, and λ(T, x,Ω) = 0 on Z × S2.
The necessary condition for the optimality of a source for PSF is of a similar
form.
Theorem 3.4. For a given distribution of cells ρi, i = 0, 1, . . . N and the associated
linear-quadratic cell death parameters αi, βi > 0, a locally optimal q
∗ ∈ L2ad([0, T ]×
Z × S2) for JSF must be such that
(10) q∗(t, x,Ω) = proj
[0,U(x)]
(
− 1
c2(x)
λ∗(t, x,Ω)
)
where λ∗ = E∗(r∗) for
r∗ =
[(− α0 − 2β0Dψ∗)(c0ρ0 exp[−α0Dψ∗ − β0(Dψ∗)2])]
−
N∑
i=1
[(− αi − 2βiDψ∗)(ciρi exp[−αiDψ∗ − βi(Dψ∗)2])]
and ψ∗ = E(q∗).
Proof. The reduced cost functional jSF (q) = JSF (E(q), q) is Fre´chet differentiable
due to the differentiability of the integrands in JSF and the linearity and continuity
of E . For simplicity, we assume ρ0 ≡ 1 (and thus ρi ≡ 0 for i ≥ 1) first. We then
get that for a locally optimal q∗ and any other admissible control q,
j′SF (q
∗)(q − q∗) ≥ 0
where, by the linearity of the adjoint solution operator E∗ and the chain rule,
j′SF (q
∗)(q − q∗) = c0
∫
Z
(− α0 − 2β0DE(q∗))(c0ρ0 exp[−α0DE(q∗)− β0(DE(q∗))2])E(q − q∗)
+ c2
∫
Z
q∗(q − q∗)
=
∫
Z
E∗((−α0 − 2β0DE(q∗)
)(
c0ρ0 exp[−α0DE(q∗)− β0(DE(q∗))2]
)
(q − q∗)
+ c2
∫
Z
q∗(q − q∗).
8RICHARD BARNARD∗ , MARTIN FRANK, MICHAEL HERTY RWTH AACHEN UNIVERSITY, AACHEN GERMANY
This leads to the minimum principle (by an argument analogous to that found on
pages 68-70 of [17]), which states that
min
q∈L2ad([0,T ]×Z×S2)
[(λ∗ + c2q∗)q]
is attained almost everywhere at q∗ which leads us to conclude that q∗ satisfies
(10). Now if we drop the assumption that ρi ≡ 1, and allow for the presence of
other species, the argument follows through in a nearly identical fashion. 
This gives the necessary optimality system
(11)

−Aψ∗ + Σψ∗ = Kψ∗ + q∗,
Aλ∗ + Σλ∗ = Kλ∗ + r∗,
q∗ = proj[0,U(x)](− 1c2λ∗)
where r∗ is as in Theorem 3.4.
4. Minimum entropy closure
For our purposes, solving (1) in full is unnecessary. We note that both JT and
JSF do not need the exact photon densities as functions of the angular variable; it
would be enough to determine the zeroth moment, which is the total energy at a
given (t, x):
ψ(0)(t, x) =
∫
S2
ψ(t, x,Ω)dΩ.
In light of this, we average (1) over the angular variable and obtain
(12) ∂tψ
(0)(t, x) +∇x · ψ(1)(t, x) + σt(x)ψ(0)(t, x) = σs(x)ψ(0)(t, x) + q(0)(t, x)
where
ψ(1)(t, x) =
∫
S2
Ωψ(t, x,Ω)dΩ
is the first moment, or the flux vector and q(0) is the average of q over all directions.
By multiplying (1) by Ω and taking the average over all directions, we get
(13) ∂tψ
(1)(t, x) +∇x · ψ(2)(t, x) + σt(x)ψ(1)(t, x) = σs(x)gψ(1)(t, x) + q(1)(t, x)
where
ψ(2)(t, x) =
∫
S2
(Ω⊗ Ω)ψ(t, x,Ω)dΩ
is the second moment, or the pressure tensor of the radiation field, and q(1) is the
first moment of the control. We note that if we continued this process of multiplying
(1) by monomials of Ω and integrating over S2, we would always have an equation
relating the nth moment to the (n+1)th moment. If we want a closed system, then,
we must select an approximation to the (n+ 1)th moment
ψ(n+1) = D(ψ(0), . . . , ψ(n)).
Here, we consider the minimum entropy closure (M1) to approximate ψ
(2). This
involves searching for I which minimizes
H∗R(I) =
∫
S2
h∗R(I)dΩ
where
h∗R(I) = 2kν
2(n log n− (n+ 1) log(n+ 1)), with n = I
2hν3
,
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and k is the Boltzmann constant, h is the Planck constant, and ν is the frequency
of the radiation. We constrain the entropy minimization by requiring, naturally,
that ∫
S2
IdΩ = ψ(0), and
∫
S2
ΩIdΩ = ψ(1).
in [6], the entropy minimizer was obtained explicitly by setting
ψ(2) = D(f)E
where the relative flux is f = ψ(1)/ψ(0), the Eddington tensor D, is
D(f) =
1− χ(f)
2
I +
3χ(f)− 1
2
f ⊗ f
|f |2
and the Eddington factor χ is
χ(f) =
1
3
(5− 2
√
4− 3|f |2).
This choice of the Eddington factor preserves several reasonable physical properties.
Importantly, the flux is limited; that is, |f | < 1. This preserves the finite bound
the speed that information travels through the system. Also, the distribution is
nonnegative, which we would like to ensure. We note that neither property is sat-
isfied for several common closure choices which use a diffusion approximation, such
as the spherical harmonics method(also known as PN methods) [3]. In [7], the M1
approximation was seen via numerical tests to provide a high quality approximation
when compared with Monte Carlo-based methods.
Despite these advantages, the M1 does have several drawbacks. Due to the non-
linearity of the M1 approximation (as opposed to the PN approximation [10]), we
can not expect that the systems obtained by applying the M1 approximation to
the optimality systems will match the optimality systems obtained by optimizing
the M1 approximation to (1). Also, as mentioned briefly above, the use of moment
models complicates the incorporation of boundary conditions. The boundary con-
dition (4) describes only the incoming particles, whereas boundary conditions for
(12) and (13) require us to prescribe values for the full moments. In light of this,
we use U(x) to approximate boundary control by setting it as
U(x) =
{
qmax, if d∂Z(x) ≤ 
δ otherwise,
where qmax > 0 is a total maximum source level, , δ > 0 are sufficiently small
parameters, and d∂Z denotes the usual distance from the boundary of Z. We note
that the first two equations in both (9) and (11) are very similar and we thus use the
M1 closure to solve the state and adjoint equations. That is, we take an optimize-
then-discretize approach to PT and PSF as opposed to a discretize-then-optimize
approach.
5. 2-D Numerical Tests
In this section, we study the 2-dimensional region Z := [−1, 1] × [−1, 1]. We
define a void-like region ZV := {0.8 ≤ |x| ≤ 0.9} On ZV , the scattering and
absorbtion cross-sections σs, σa have values that differ from those elsewhere; these
are summarized in Table 1 for the specific values.
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ZV Z \ ZV
σa 0.001 0.05
σs 0.01 0.5
Table 1. Material parameters for PSF
ZT ZR ZN
α 0.52 0.170 0.170
β 0.171 0.0078 0.0078
Table 2. Cell-response parameters for PSF
ZT ZR
Basic Target [−0.25, 0.25]× [−0.25, 0.25] [.254, 0.379]× [−0.125, 0.125]
Intermediate Target
([−0.25, 0.25]× [−0.25, 0]) [0.04, 0.25]× [0.04, 0.25]
∪([−0.25, 0]× [0, 0.25])
Complex Target
([−0.25, 0.25]× [−0.25,−0.125]) [−0.25,−0.04]× [−0.121, 0.121]
∪([−0.25, 0.25]× [0.125, 0.25])
∪([0.04, 0.25]× [−0.125, 0.125])
Table 3. Locations of Tumor and Risk Region
The final parameter of the physical medium to be defined is the scattering phase
function. For simplicity in our test problem, we define g ≡ 0.85. Other, more
involved, kernels might be used in this range for g to agree with Mie scattering
theory as in [1].
For testing, we use three tumor/risk region regions similar to those in [13]. Specif-
ically, we define the regions in Table 3 and are shown in Figure 1; the void region
is shown in black and the tumor and risk regions are traced in white. In the basic
target case, seen in Figure 1(a), the tumor region is a box, as is the risk region. The
second, intermediate target case, seen in Figure 1(b), involves an L-shaped tumor
around a box-shaped risk region. Finally, the complex target case in Figure 1(c)
involves a C-shaped tumor around a risk region. We will solve both PT and PSF
for each geometry seen in Figure 1. For PT for each example, we set D ≡ T on ZT
and 0 elsewhere, corresponding to an average (over time) dose of 1, and
c1 = cTχZT + cRχZR + cNχZN
with cT = 25, cR = 150, cN = 1. For PSF , we set ρ0 ≡ χZT , ρ1 ≡ χZR , ρ2 ≡
χZN , with weights a0 = 500, a1 = 2000, a2 = 1. The LQ parameters are shown
below; the tumor region uses parameters for Lewis Lung tumor cells and the risk
region and normal region use parameters for V79 (normal Chinese hamster lung
tissue); both sets of parameters are taken from [16]. We use a simple gradient
descent algorithm to determine an optimal control for each of the three targets
and for each objective functional. The M1 approximations to both the state and
adjoint equations are solved with a finite volume solver using approximately 10,000
cells with final time T = 5. The parameters δ and  in the definition of U(x)
are chosen as min{∆x,∆y}(10−4)t and min{∆x,∆y}, respectively, where ∆x,∆y
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(a) Basic Target (b) Intermediate Target
(c) Complex Target
Figure 1. Example cases
are the mesh sizes. We consider the algorithm as converged if both the difference
between consecutive iterates and ||j′(q)||∞ are smaller than 10−4.
Figure 2 shows the optimal boundary source term for both PT and PSF . The
vectors shown on the boundary are the time-integrated values of q(1) normalized
and then scaled by q(0). In Figures 2(a), 2(c), and 2(e) (corresponding to PT ), the
isolines are spaced at 5% intervals of the maximum of the desired dose (here, 5).
In the intermediate and tracking cases, we see that relatively low dose levels are
attained, primarily due to the high penalty to any dose deposited in the risk region.
In Figures 2(b), 2(d), and 2(f)(corresponding to PSF ), the isolines are spaced at
intervals of 10% of cells killed. Here a high proportion of the tumor cells are killed
(in each case 80%− 90%) while in the Intermediate and Basic cases, the tumor has
at least 60% survival; in the Complex case, the risk region has 50%− 60% survival.
The dose deposited in PT changes significantly when we alter the relative weights
cT and cR. In Figure ??, we see the results for solving PT , and PSF where we set
cR = 50 and a1 = 1000 (all other parameters are unchanged). In both the basic
and intermediate cases, the dose delivered to the tumor is significantly higher while
also remaining largely concentrated on the tumor. This is slightly less true in the
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(a) Tracking, Basic Target (b) Surviving Fraction, Basic Target
(c) Tracking, Intermediate Target (d) Surviving Fraction, Intermediate
Target
(e) Tracking, Complex Target (f) Surviving Fraction, Complex Target
Figure 2. Optimal boundary source for PT , in (a),(c),(e) and
PSF in (b),(d),(f)
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complex case. In the figures for PSF , there is no general change in the pattern
of cell death, however the risk region in the first two cases has 50% cell survival
whereas the complex case has approximately 40% − 50% cell survival. However,
this lack of change in pattern can partially be attributed to the tumor cells being
more susceptible to the radiation dose.
We conclude with a final set of numerical examples which restrict the location
of the source by altering the definition of U(x). Here we require that q ≤ δ on
one side of the boundary. For the basic and intermediate case, we require that the
external source not come from the left side of Z. For the complex case, we disallow
sources on the right side (as the optimal source is nearly zero on the right side in
the complex case for PT ). Figure 4 shows the optimal solution for both problems,
using the same penalization parameters used in Figure 2. The optimal dose for PT
is significantly worse, with the tumor in the intermediate and complex cases getting
a dose below 3. However, the tumor cells have a survival of 10% or less for each
case and the risk region has a survival rate of 60% or higher in each case.
Clearly, the choice of relative weights cT , cR and ai affects the optimal solution.
However, we have currently no systematic a priori method of selecting the relative
weights in either problem. Such a method should take into account the relative
importance of the different tissues and the susceptibilities of the various cell types,
leading to a possibly nonintuitive scheme. Without such a method, several opti-
mization runs may be required to find an appropriate treatment strategy. We also
note that the optimization does not consider the feasibility of the optimal source.
In fact, the optimal boundary control in all of the numerical results are spread out
along the boundary, as opposed to being focused in a beam configuration. Further
modeling would be required in order for the cost function to penalize non-beam like
configurations.
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